$GKOS
GLAUKOS Corp

2020 Q2 Form 10-Q Financial Statement

#000155837020005773 Filed on May 07, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2020 Q1 2019 Q1
Revenue $31.56M $55.34M $54.03M
YoY Change -46.15% 2.42% 34.62%
Cost Of Revenue $21.67M $32.53M $7.111M
YoY Change 175.32% 357.45% 22.9%
Gross Profit $9.890M $22.81M $46.92M
YoY Change -80.5% -51.39% 36.59%
Gross Profit Margin 31.34% 41.22% 86.84%
Selling, General & Admin $38.12M $50.55M $34.93M
YoY Change 1.22% 44.73% 28.61%
% of Gross Profit 385.4% 221.62% 74.44%
Research & Development $18.97M $24.87M $13.93M
YoY Change 11.14% 78.56% 27.73%
% of Gross Profit 191.82% 109.06% 29.69%
Depreciation & Amortization $7.330M $1.082M $842.0K
YoY Change 723.6% 28.5% -49.58%
% of Gross Profit 74.12% 4.74% 1.79%
Operating Expenses $57.09M $75.42M $48.86M
YoY Change 0.21% 54.37% 28.36%
Operating Profit -$47.20M -$52.61M -$1.940M
YoY Change 656.36% 2611.96% -47.77%
Interest Expense -$1.280M -$2.190M $690.0K
YoY Change -1522.22% -417.39% -32.35%
% of Operating Profit
Other Income/Expense, Net -$81.00K -$1.896M $720.0K
YoY Change -2800.0% -363.33% -28.57%
Pretax Income -$47.28M -$54.51M -$1.220M
YoY Change 658.02% 4367.87% -54.98%
Income Tax -$7.384M -$450.0K $122.0K
% Of Pretax Income
Net Earnings -$39.89M -$54.06M -$1.342M
YoY Change 532.33% 3928.17% -50.5%
Net Earnings / Revenue -126.41% -97.69% -2.48%
Basic Earnings Per Share -$0.90 -$1.24 -$0.04
Diluted Earnings Per Share -$0.90 -$1.24 -$0.04
COMMON SHARES
Basic Shares Outstanding 44.23M 43.74M 36.21M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q2 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $394.9M $163.7M $145.3M
YoY Change 162.57% 12.66% 27.68%
Cash & Equivalents $267.0M $53.61M $42.49M
Short-Term Investments $128.0M $110.1M $111.6M
Other Short-Term Assets $10.50M $11.10M $4.400M
YoY Change -28.57% 152.27% 33.33%
Inventory $21.09M $27.70M $13.40M
Prepaid Expenses
Receivables $26.73M $28.89M $20.60M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $453.2M $231.4M $183.7M
YoY Change 125.26% 25.96% 24.63%
LONG-TERM ASSETS
Property, Plant & Equipment $23.21M $22.76M $32.30M
YoY Change 13.24% -29.54% 166.94%
Goodwill $66.13M $66.13M
YoY Change
Intangibles $370.1M $376.4M
YoY Change
Long-Term Investments
YoY Change
Other Assets $15.90M $14.60M $12.00M
YoY Change 14.39% 21.67% 605.88%
Total Long-Term Assets $542.5M $548.3M $44.30M
YoY Change 437.76% 1137.77% 176.88%
TOTAL ASSETS
Total Short-Term Assets $453.2M $231.4M $183.7M
Total Long-Term Assets $542.5M $548.3M $44.30M
Total Assets $995.7M $779.7M $228.0M
YoY Change 229.62% 241.98% 39.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.233M $12.94M $5.700M
YoY Change 82.76% 127.07% 18.75%
Accrued Expenses $45.60M $38.13M $21.70M
YoY Change 75.72% 75.73% 58.39%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $54.83M $51.08M $27.30M
YoY Change 76.87% 87.1% 46.77%
LONG-TERM LIABILITIES
Long-Term Debt $244.4M $59.30M $0.00
YoY Change 258.36%
Other Long-Term Liabilities $5.489M $4.491M $15.20M
YoY Change 60.83% -70.45% 794.12%
Total Long-Term Liabilities $5.489M $4.491M $15.20M
YoY Change 60.83% -70.45% 794.12%
TOTAL LIABILITIES
Total Short-Term Liabilities $54.83M $51.08M $27.30M
Total Long-Term Liabilities $5.489M $4.491M $15.20M
Total Liabilities $333.3M $138.4M $42.50M
YoY Change 191.66% 225.7% 109.36%
SHAREHOLDERS EQUITY
Retained Earnings -$283.7M -$243.8M
YoY Change 33.31%
Common Stock $943.8M $883.2M
YoY Change 136.24%
Preferred Stock
YoY Change
Treasury Stock (at cost) $132.0K $132.0K
YoY Change 0.0%
Treasury Stock Shares $28.00K $28.00K
Shareholders Equity $662.4M $641.3M $185.5M
YoY Change
Total Liabilities & Shareholders Equity $995.7M $779.7M $228.0M
YoY Change 229.62% 241.98% 39.53%

Cashflow Statement

Concept 2020 Q2 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income -$39.89M -$54.06M -$1.342M
YoY Change 532.33% 3928.17% -50.5%
Depreciation, Depletion And Amortization $7.330M $1.082M $842.0K
YoY Change 723.6% 28.5% -49.58%
Cash From Operating Activities -$10.92M -$13.10M $208.0K
YoY Change -265.45% -6397.6% -103.22%
INVESTING ACTIVITIES
Capital Expenditures -$2.730M $782.0K $651.0K
YoY Change 45.99% 20.12% -152.08%
Acquisitions
YoY Change
Other Investing Activities -$17.94M $1.410M -$1.060M
YoY Change -1512.6% -233.02% -73.57%
Cash From Investing Activities -$20.67M $628.0K -$1.713M
YoY Change 3345.0% -136.66% -67.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 243.8M 4.220M 5.407M
YoY Change 76100.0% -21.95% 90.39%
NET CHANGE
Cash From Operating Activities -10.92M -13.10M 208.0K
Cash From Investing Activities -20.67M 628.0K -1.713M
Cash From Financing Activities 243.8M 4.220M 5.407M
Net Change In Cash 212.3M -8.816M 3.897M
YoY Change 3258.39% -326.23% -143.98%
FREE CASH FLOW
Cash From Operating Activities -$10.92M -$13.10M $208.0K
Capital Expenditures -$2.730M $782.0K $651.0K
Free Cash Flow -$8.190M -$13.88M -$443.0K
YoY Change -196.69% 3033.41% -91.48%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
GLAUKOS Corp
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001192448
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 us-gaap Lessee Operating Lease Lease Not Yet Commenced Existence Of Option To Extend
LesseeOperatingLeaseLeaseNotYetCommencedExistenceOfOptionToExtend
true
CY2020Q1 us-gaap Revenue Practical Expedient Initial Application And Transition Nondisclosure Of Transaction Price Allocation To Remaining Performance Obligation
RevenuePracticalExpedientInitialApplicationAndTransitionNondisclosureOfTransactionPriceAllocationToRemainingPerformanceObligation
true
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q1 dei Entity File Number
EntityFileNumber
001-37463
CY2020Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0945406
CY2020Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
229 Avenida Fabricante
CY2020Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
San Clemente
CY2020Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2020Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92672
CY2020Q1 dei City Area Code
CityAreaCode
949
CY2020Q1 dei Local Phone Number
LocalPhoneNumber
367-9600
CY2020Q1 dei Security12b Title
Security12bTitle
Common Stock
CY2020Q1 dei Trading Symbol
TradingSymbol
GKOS
CY2020Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
44230319
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
53614000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
62430000
CY2020Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
110096000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
111553000
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
28885000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
38417000
CY2020Q1 us-gaap Inventory Net
InventoryNet
27699000
CY2019Q4 us-gaap Inventory Net
InventoryNet
42578000
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11092000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7900000
CY2020Q1 us-gaap Assets Current
AssetsCurrent
231386000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
262878000
CY2020Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
9326000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
9326000
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22760000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22056000
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
15059000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
15704000
CY2020Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
53441000
CY2019Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
54048000
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
376377000
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
382605000
CY2020Q1 us-gaap Goodwill
Goodwill
66134000
CY2019Q4 us-gaap Goodwill
Goodwill
66134000
CY2020Q1 gkos Deposit Assets And Other Assets Noncurrent
DepositAssetsAndOtherAssetsNoncurrent
5237000
CY2019Q4 gkos Deposit Assets And Other Assets Noncurrent
DepositAssetsAndOtherAssetsNoncurrent
5649000
CY2020Q1 us-gaap Assets
Assets
779720000
CY2019Q4 us-gaap Assets
Assets
818400000
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
12943000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5781000
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
38134000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
51919000
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
51077000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
57700000
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
13601000
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14195000
CY2020Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
59316000
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
58435000
CY2020Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
9936000
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
9632000
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4491000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5166000
CY2020Q1 us-gaap Liabilities
Liabilities
138421000
CY2019Q4 us-gaap Liabilities
Liabilities
145128000
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44119000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43530000
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44091000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43502000
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
44000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
44000
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
883136000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
861740000
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2019000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1330000
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-243768000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-189710000
CY2020Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
28000
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
28000
CY2020Q1 us-gaap Treasury Stock Value
TreasuryStockValue
132000
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
132000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
641299000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
673272000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
779720000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
818400000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
55336000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
54026000
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
32529000
CY2019Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7111000
CY2020Q1 us-gaap Gross Profit
GrossProfit
22807000
CY2019Q1 us-gaap Gross Profit
GrossProfit
46915000
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
50546000
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
34925000
CY2020Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
24873000
CY2019Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
13930000
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
75419000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
48855000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-52612000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1940000
CY2020Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
696000
CY2019Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
788000
CY2020Q1 gkos Interest And Other Expense Income
InterestAndOtherExpenseIncome
-881000
CY2020Q1 gkos Interest And Other Expense Net
InterestAndOtherExpenseNet
1711000
CY2019Q1 gkos Interest And Other Expense Net
InterestAndOtherExpenseNet
68000
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1896000
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
720000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-54508000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1220000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-450000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
122000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-54058000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-1342000
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.24
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
43766000
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
36205000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-54058000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-1342000
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1169000
CY2019Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
-112000
CY2019Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
64000
CY2020Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-480000
CY2019Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
372000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
689000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
436000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-53369000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-906000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
673272000
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
4220000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17176000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
689000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-54058000
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
641299000
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
173860000
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
5406000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7129000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
436000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-1342000
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
185489000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-54058000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-1342000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7310000
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
842000
CY2020Q1 gkos Amortization Operating Lease Right Of Use Asset
AmortizationOperatingLeaseRightOfUseAsset
1311000
CY2019Q1 gkos Amortization Operating Lease Right Of Use Asset
AmortizationOperatingLeaseRightOfUseAsset
400000
CY2020Q1 gkos Change In Deferred Income Tax Expense Benefit
ChangeInDeferredIncomeTaxExpenseBenefit
-709000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
17176000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7129000
CY2020Q1 gkos Stock Option Plan Expenses
StockOptionPlanExpenses
-3171000
CY2020Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-2024000
CY2019Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-87000
CY2020Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
-19000
CY2020Q1 gkos Deferred Rent And Other Liabilities Adjustment
DeferredRentAndOtherLiabilitiesAdjustment
207000
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1959000
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-14568000
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
157000
CY2020Q1 gkos Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
-2235000
CY2019Q1 gkos Deferred Rent And Other Liabilities Adjustment
DeferredRentAndOtherLiabilitiesAdjustment
689000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-9246000
CY2019Q1 gkos Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
-173000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4750000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-5134000
CY2020Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-1000
CY2019Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
62000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13099000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
208000
CY2020Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
18680000
CY2019Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
16613000
CY2020Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
19676000
CY2019Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
16189000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
782000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
651000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
628000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1713000
CY2020Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4454000
CY2019Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4607000
CY2020Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
1278000
CY2019Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
902000
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1512000
CY2019Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
102000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4220000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5407000
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-565000
CY2019Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-5000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8816000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3897000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
71756000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
38596000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
62940000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
42493000
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
250000
CY2019Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
40000
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
401000
CY2020Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman';font-size:10pt;margin:0pt 0pt 6pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt;">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates and assumptions. Management considers many factors in selecting appropriate financial accounting policies and controls and in developing the estimates and assumptions that are used in the preparation of these condensed consolidated financial statements. Management must apply significant judgment in this process. In addition, other factors may affect estimates, including expected business and operational changes, sensitivity and volatility associated with the assumptions used in developing estimates, and whether historical trends are expected to be representative of future trends. The estimation process often may yield a range of reasonable estimates of the ultimate future outcomes, and management must select an amount that falls within that range of reasonable estimates. The most significant estimates in the accompanying condensed consolidated financial statements relate to revenue recognition, the incremental borrowing rate related to the Company’s leased assets, stock-based compensation expense and the valuation of certain intangible assets related to the Company’s acquisition of Avedro. Although these estimates are based on the Company’s knowledge of current events and actions it may undertake in the future, this process may result in actual results differing materially from those estimated amounts used in the preparation of the condensed consolidated financial statements. </p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="color:#212529;">In </span>March 2020, the World Health Organization declared the outbreak caused by the novel strain of coronavirus (COVID-19) to be a global pandemic. While COVID-19 continues to evolve daily and its ultimate outcome is uncertain, it has caused significant disruption to individuals, governments, businesses, and financial markets. The Company’s condensed consolidated financial statements as of and for the three months ended March 31, 2020 reflect the Company’s estimates of the impact of the COVID-19 outbreak. The full extent to which the COVID-19 pandemic will directly or indirectly impact our business, results of operations and financial condition, including sales, expenses, reserves and allowances, manufacturing, clinical trials, research and development costs and employee-related amounts, will depend on future developments that are highly uncertain, including the duration and severity of the COVID-19 outbreak and the actions taken to contain it or treat COVID-19, as well as the economic impact on local, regional, national and </p><p style="font-family:'Times New Roman';font-size:10pt;margin:0pt;">international customers and markets. As a result, there may be changes to the Company’s estimates regarding the impact of COVID-19 in future periods.</p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p>
CY2020Q1 gkos Number Of Business Activities
NumberOfBusinessActivities
1
CY2020Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1200000
CY2019Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
100000
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-2000000.0
CY2019Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-100000
CY2020Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
110183000
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
314000
CY2020Q1 us-gaap Trading Securities
TradingSecurities
0
CY2019Q4 us-gaap Trading Securities
TradingSecurities
0
CY2020Q1 gkos Restricted Cash Pledged For Letter Of Credit
RestrictedCashPledgedForLetterOfCredit
8800000
CY2019Q4 gkos Restricted Cash Pledged For Letter Of Credit
RestrictedCashPledgedForLetterOfCredit
8800000
CY2020Q1 gkos Number Of Months Of Lease Term For Adjustments Of Letters Of Credit Balance Outstanding To Begin
NumberOfMonthsOfLeaseTermForAdjustmentsOfLettersOfCreditBalanceOutstandingToBegin
37
CY2020Q1 gkos Frequency Of Adjustments Of Letters Of Credit Balance Outstanding
FrequencyOfAdjustmentsOfLettersOfCreditBalanceOutstanding
P12M
CY2020Q1 gkos Adjustment Percentage Of Letters Of Credit Balance Outstanding
AdjustmentPercentageOfLettersOfCreditBalanceOutstanding
0.20
CY2020Q1 gkos Minimal Amount Of Letters Of Credit Balance Outstanding After Adjustments
MinimalAmountOfLettersOfCreditBalanceOutstandingAfterAdjustments
2000000.0
CY2020Q1 gkos Number Of Other Irrevocable Letters Of Credit Outstanding
NumberOfOtherIrrevocableLettersOfCreditOutstanding
2
CY2020Q1 gkos Restricted Cash Pledged For Office Lease Agreement
RestrictedCashPledgedForOfficeLeaseAgreement
400000
CY2020Q1 gkos Restricted Cash Pledged For Credit Card Program
RestrictedCashPledgedForCreditCardProgram
200000
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
53614000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
62430000
CY2020Q1 us-gaap Restricted Cash
RestrictedCash
9326000
CY2019Q4 us-gaap Restricted Cash
RestrictedCash
9326000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
62940000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
71756000
CY2020Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman';font-size:10pt;margin:0pt 0pt 9pt 0pt;"><span style="font-style:italic;font-weight:bold;">Concentration of Credit Risk and Significant Customers</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt 0pt 9pt 0pt;">Financial instruments, which potentially subject the Company to significant concentration of credit risk, consist primarily of cash, cash equivalents, short-term investments and accounts receivable. The Company maintains deposits in federally insured financial institutions in excess of federally insured limits and management believes that the Company is not exposed to significant credit risk due to the financial position of the depository institutions in which those deposits are held. Additionally, the Company has established guidelines regarding investment instruments and their maturities which are designed to maintain preservation of principal and liquidity. The Company believes that the concentration of credit risk in its accounts receivable is mitigated by its credit evaluation process, relatively short collection terms and the level of credit worthiness of its customers. During the three months ended March 31, 2020 and March 31, 2019, none of the Company’s customers accounted for more than 10% of revenues. </p>
CY2019Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
6685000
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1600000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1200000
CY2020Q1 us-gaap Inventory Write Down
InventoryWriteDown
7900000
CY2019Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2020Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4804000
CY2020Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2020Q1 gkos Number Of Performance Obligations For Majority Of Contracts With Customers
NumberOfPerformanceObligationsForMajorityOfContractsWithCustomers
1
CY2020Q1 gkos Standard Warranty Period
StandardWarrantyPeriod
P1Y
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3939000
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3957000
CY2020Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
110096000
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
111161000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
409000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
17000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
111553000
CY2020Q1 us-gaap Accounts Receivable Gross
AccountsReceivableGross
30472000
CY2019Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
39657000
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1587000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1240000
CY2020Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
28885000
CY2019Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
38417000
CY2020Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
18108000
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
32108000
CY2020Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
2730000
CY2019Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
3884000
CY2020Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
6861000
CY2019Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
6586000
CY2020Q1 us-gaap Inventory Gross
InventoryGross
27699000
CY2019Q4 us-gaap Inventory Gross
InventoryGross
42578000
CY2020Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
4149000
CY2019Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
13525000
CY2020Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
3201000
CY2019Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
2784000
CY2020Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4277000
CY2020Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
26507000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
31653000
CY2020Q1 gkos Accrued Liabilities And Employee Related Liabilities Current
AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent
38134000
CY2019Q4 gkos Accrued Liabilities And Employee Related Liabilities Current
AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent
51919000
CY2020Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
115571000
CY2020Q1 gkos Cash Settled Stock Options Liability Fair Value Disclosure
CashSettledStockOptionsLiabilityFairValueDisclosure
2165000
CY2020Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
2165000
CY2019Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
115284000
CY2019Q4 gkos Cash Settled Stock Options Liability Fair Value Disclosure
CashSettledStockOptionsLiabilityFairValueDisclosure
6685000
CY2019Q1 gkos Fair Value Assets And Liabilities Level1 Level2 And Level3 Transfers Amount
FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount
0
CY2020Q1 gkos Fair Value Assets And Liabilities Level1 Level2 And Level3 Transfers Amount
FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount
0
CY2020Q1 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2020Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P10Y
CY2020Q1 us-gaap Lessee Operating Lease Existence Of Option To Terminate
LesseeOperatingLeaseExistenceOfOptionToTerminate
true
CY2020Q1 gkos Lessee Operating Lease Period For Lease Termination
LesseeOperatingLeasePeriodForLeaseTermination
P1Y
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
15059000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
15704000
CY2020Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
53441000
CY2019Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
54048000
CY2020Q1 gkos Lease Right Of Use Asset
LeaseRightOfUseAsset
68500000
CY2019Q4 gkos Lease Right Of Use Asset
LeaseRightOfUseAsset
69752000
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2401000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2401000
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
13601000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14195000
CY2020Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
59316000
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
58435000
CY2020Q1 gkos Finance And Operating Lease Liability
FinanceAndOperatingLeaseLiability
75318000
CY2019Q4 gkos Finance And Operating Lease Liability
FinanceAndOperatingLeaseLiability
75031000
CY2020Q1 gkos Coronavirus Aid Relief And Economic Security Act Carryback Net Operating Losses Period
CoronavirusAidReliefAndEconomicSecurityActCarrybackNetOperatingLossesPeriod
P5Y
CY2020Q1 gkos Income Tax Expense Benefit From Coronavirus Aid Relief And Economic Security Act
IncomeTaxExpenseBenefitFromCoronavirusAidReliefAndEconomicSecurityAct
-400000
CY2020Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
938000
CY2019Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
938000
CY2020Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
607000
CY2019Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
607000
CY2020Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
881000
CY2019Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
881000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2412000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3197000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3123000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2230000
CY2020Q1 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
3543000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
2023000
CY2020Q1 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
5184000
CY2020Q1 gkos Lessee Operating Lease Liability Payments Due Year Six
LesseeOperatingLeaseLiabilityPaymentsDueYearSix
2052000
CY2020Q1 gkos Finance Lease Liability Payments Due Year Six
FinanceLeaseLiabilityPaymentsDueYearSix
5340000
CY2020Q1 gkos Lessee Operating Lease Liability Payments Due Year Seven
LesseeOperatingLeaseLiabilityPaymentsDueYearSeven
2112000
CY2020Q1 gkos Finance Lease Liability Payments Due Year Seven
FinanceLeaseLiabilityPaymentsDueYearSeven
5500000
CY2020Q1 gkos Lessee Operating Lease Liability Payments Due After Year Seven
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSeven
2111000
CY2020Q1 gkos Finance Lease Liability Payments Due After Year Seven
FinanceLeaseLiabilityPaymentsDueAfterYearSeven
107522000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
19260000
CY2020Q1 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
127089000
CY2020Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3258000
CY2020Q1 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
67773000
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
16002000
CY2020Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
59316000
CY2020Q1 gkos Lessee Operating Lease Option To Extend Value
LesseeOperatingLeaseOptionToExtendValue
12000000.0
CY2020Q1 gkos Lessee Financing Lease Option To Extend Value
LesseeFinancingLeaseOptionToExtendValue
75800000
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y4M24D
CY2020Q1 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P22Y
CY2020Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.055
CY2020Q1 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.060
CY2020Q1 gkos Intangible Assets Gross Including Goodwill
IntangibleAssetsGrossIncludingGoodwill
451334000
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8823000
CY2019Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
448739000
CY2020Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
8800000
CY2019Q1 gkos Restricted Cash Pledged For Letter Of Credit
RestrictedCashPledgedForLetterOfCredit
8800000
CY2020Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
442511000
CY2019Q4 gkos Intangible Assets Gross Including Goodwill
IntangibleAssetsGrossIncludingGoodwill
451334000
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2595000
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
864000
CY2019Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
531000
CY2020Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
61000
CY2019Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
61000
CY2020Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
266300000
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8823000
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
257477000
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
266300000
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2595000
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
263705000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
18684000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
24912000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
24912000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
24912000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
24619000
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
139438000
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
257477000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
55336000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
54026000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
55336000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
54026000
CY2020Q1 gkos Period For Payment On Invoice Terms
PeriodForPaymentOnInvoiceTerms
P30D
CY2020Q1 us-gaap Revenue Practical Expedient Financing Component
RevenuePracticalExpedientFinancingComponent
true
CY2020Q1 us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
CY2020Q1 gkos Share Based Compensation Number Of Plans
ShareBasedCompensationNumberOfPlans
4
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2020Q1 gkos Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Percentage On First Anniversary Date Of Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPercentageOnFirstAnniversaryDateOfGrant
0.25
CY2020Q1 gkos Share Based Compensation Arrangement By Share Based Payment Award Award Remaining Vesting Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRemainingVestingPeriod
P3Y
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14005000
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7129000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14000000.0
CY2020Q1 gkos Accrued Liability For Cash Settled Options Current Liabilities
AccruedLiabilityForCashSettledOptionsCurrentLiabilities
2200000
CY2020Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
49200000
CY2019Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
13600000
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0083
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-450000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
122000
CY2020Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
17800000
CY2020Q1 gkos Restricted Cash Pledged For Letter Of Credit
RestrictedCashPledgedForLetterOfCredit
8800000
CY2020Q1 gkos Number Of Months Of Lease Term For Adjustments Of Letters Of Credit Balance Outstanding To Begin
NumberOfMonthsOfLeaseTermForAdjustmentsOfLettersOfCreditBalanceOutstandingToBegin
37
CY2020Q1 gkos Frequency Of Adjustments Of Letters Of Credit Balance Outstanding
FrequencyOfAdjustmentsOfLettersOfCreditBalanceOutstanding
P12M
CY2020Q1 gkos Adjustment Percentage Of Letters Of Credit Balance Outstanding
AdjustmentPercentageOfLettersOfCreditBalanceOutstanding
0.20
CY2020Q1 gkos Minimal Amount Of Letters Of Credit Balance Outstanding After Adjustments
MinimalAmountOfLettersOfCreditBalanceOutstandingAfterAdjustments
2000000.0
CY2020Q1 gkos Number Of Other Irrevocable Letters Of Credit Outstanding
NumberOfOtherIrrevocableLettersOfCreditOutstanding
2
CY2020Q1 gkos Restricted Cash Pledged For Office Lease Agreement
RestrictedCashPledgedForOfficeLeaseAgreement
400000
CY2020Q1 gkos Restricted Cash Pledged For Credit Card Program
RestrictedCashPledgedForCreditCardProgram
200000
CY2020Q1 gkos Restructuring Headcount Reduction Number
RestructuringHeadcountReductionNumber
40
CY2020Q1 us-gaap Restructuring Reserve
RestructuringReserve
900000
CY2020Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
3600000
CY2020Q1 us-gaap Restructuring And Related Cost Expected Cost1
RestructuringAndRelatedCostExpectedCost1
5200000
CY2019Q4 us-gaap Restructuring Reserve
RestructuringReserve
4096000
CY2020Q1 us-gaap Restructuring Charges
RestructuringCharges
462000
CY2020Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
3634000
CY2020Q1 us-gaap Restructuring Reserve
RestructuringReserve
924000
CY2020Q1 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
3200000
CY2019Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
3700000
CY2020Q1 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
3100000
CY2019Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
3500000
CY2020Q1 gkos Other Commitment Obligation Amount
OtherCommitmentObligationAmount
5100000
CY2020Q1 gkos Number Of Business Activities
NumberOfBusinessActivities
1
CY2020Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1

Files In Submission

Name View Source Status
0001558370-20-005773-index-headers.html Edgar Link pending
0001558370-20-005773-index.html Edgar Link pending
0001558370-20-005773.txt Edgar Link pending
0001558370-20-005773-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gkos-20200331xex10d2.htm Edgar Link pending
gkos-20200331xex31d1.htm Edgar Link pending
gkos-20200331xex31d2.htm Edgar Link pending
gkos-20200331xex32d1.htm Edgar Link pending
gkos-20200331xex32d2.htm Edgar Link pending
gkos-20200507.xsd Edgar Link pending
gkos-20200507x10q.htm Edgar Link pending
gkos-20200507x10q_htm.xml Edgar Link completed
gkos-20200507_cal.xml Edgar Link unprocessable
gkos-20200507_def.xml Edgar Link unprocessable
gkos-20200507_lab.xml Edgar Link unprocessable
gkos-20200507_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending